The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.
This year's sympoisum had an overall topic of pharmcogenesy which was a favorite area of Dean Schwarting's. This presentation is a Law CE revolving around psychodelic drugs used to treat Mental Health Disorders.
1. Review the development of the knowledge of the effects of psychedelic drugs and their potential use in
psychiatry, with an emphasis on psilocybin.
2. Characterize the traditional legal classification of psychedelic drugs and modern reconsideration of their legal
3. Describe efforts at the state level to expand the medical use of psychedelic drugs.
Released: April 27, 2023
Expires: April 27, 2026
ACPE UAN Codes
1.0 hours of CE
|The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour for completing the activity (ACPE UAN 0009-0000-22-017-H03-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.
Gerald Gianutsos, PhD, JD,
University of Connecticut School of Pharmacy
Dr. Gianutsos has no financial relationships with any ineligible company associated with this presentation.
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.